Corvus Pharmaceuticals CRVS Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Corvus Pharmaceuticals’s reported figures.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's invested capital?
- Corvus Pharmaceuticals (CRVS) reported invested capital of $201.41M in Q1 2026.
- How has Corvus Pharmaceuticals's invested capital changed year-over-year?
- Corvus Pharmaceuticals's invested capital increased by 342.9% year-over-year, from $45.48M to $201.41M.
- What is the long-term trend for Corvus Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's invested capital has grown at a -0.2% compound annual growth rate (CAGR), from $58M to $57.57M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).